Omeros Corp (OMER)
3.92
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
3.92
0.00 (0.00%)
After-Hours: 20:00
Omeros Accounts Receivable (Quarterly): 6.806M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.806M |
March 31, 2024 | 6.986M |
December 31, 2023 | 6.724M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 212.97M |
September 30, 2022 | 13.11M |
June 30, 2022 | 13.67M |
March 31, 2022 | 15.85M |
December 31, 2021 | 35.47M |
September 30, 2021 | 33.62M |
June 30, 2021 | 31.42M |
March 31, 2021 | 24.58M |
December 31, 2020 | 3.771M |
September 30, 2020 | 37.22M |
June 30, 2020 | 15.69M |
March 31, 2020 | 24.01M |
December 31, 2019 | 35.07M |
September 30, 2019 | 29.81M |
June 30, 2019 | 28.38M |
March 31, 2019 | 24.58M |
December 31, 2018 | 22.65M |
September 30, 2018 | 2.165M |
June 30, 2018 | 1.50M |
Date | Value |
---|---|
March 31, 2018 | 0.049M |
December 31, 2017 | 17.08M |
September 30, 2017 | 24.57M |
June 30, 2017 | 19.08M |
March 31, 2017 | 13.48M |
December 31, 2016 | 11.94M |
September 30, 2016 | 10.46M |
June 30, 2016 | 8.806M |
March 31, 2016 | 6.646M |
December 31, 2015 | 6.344M |
September 30, 2015 | 2.51M |
June 30, 2015 | 3.071M |
March 31, 2015 | 0.538M |
December 31, 2014 | 0.324M |
September 30, 2014 | 0.381M |
June 30, 2014 | 0.252M |
March 31, 2014 | 0.488M |
December 31, 2013 | 0.308M |
September 30, 2013 | 0.881M |
June 30, 2013 | 0.715M |
March 31, 2013 | 2.003M |
December 31, 2012 | 0.402M |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2023
212.97M
Maximum
Dec 2022
27.34M
Average
15.77M
Median
Accounts Receivable (Quarterly) Benchmarks
Harrow Inc | 51.99M |
Amphastar Pharmaceuticals Inc | 131.41M |
PetIQ Inc | 214.98M |
Alector Inc | -- |
Outset Medical Inc | 34.12M |